📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Recent advances in the design of RAR a and RAR ß agonists as orally bioavailable drugs. A review. (2020)

First Author: Borthwick AD

Attributed to: A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmc.2020.115664

PubMed Identifier: 33069074

Publication URI: http://europepmc.org/abstract/MED/33069074

Type: Journal Article/Review

Volume: 28

Parent Publication: Bioorganic & medicinal chemistry

Issue: 20

ISSN: 0968-0896